loader
Please Wait
Applying Filters...
Close
4

Minakem Generic APIs Minakem Generic APIs

X

List of Drug Master Files (KDMF) for Baloxavir Marboxil Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Shionogi Pharma Co., Ltd. (Tokushima Plant) (1)

filter

01 Korea Roche Co., Ltd. (1)

filter

01 baloxavir marboxil (1)

filter

01 Japan (1)

URL Supplier Web Content
Korea Roche Co., Ltd.
2019-11-22
Number 188-4-ND
Shionogi Pharma Co., Ltd....
Japan
224-20, Hiraishiebisuno, ...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1830312-72-5 / Baloxavir Marboxil API manufacturers, exporters & distributors?

Baloxavir Marboxil manufacturers, exporters & distributors 1

40

PharmaCompass offers a list of Baloxavir Marboxil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Baloxavir Marboxil manufacturer or Baloxavir Marboxil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Baloxavir Marboxil manufacturer or Baloxavir Marboxil supplier.

PharmaCompass also assists you with knowing the Baloxavir Marboxil API Price utilized in the formulation of products. Baloxavir Marboxil API Price is not always fixed or binding as the Baloxavir Marboxil Price is obtained through a variety of data sources. The Baloxavir Marboxil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Baloxavir Marboxil

Synonyms

1985606-14-1, Xofluza, Baloxavir-marboxil, Baloxavir marboxil [inn], S-033188, 505cxm6ohg

Cas Number

1830312-72-5

Unique Ingredient Identifier (UNII)

505CXM6OHG

About Baloxavir Marboxil

Baloxavir Marboxil is an orally bioavailable prodrug and influenza cap-dependent endonuclease (CEN) inhibitor, with antiviral activity. Upon administration of baloxavir marboxil, the agent is converted by hydrolysis to its active metabolite baloxavir. Baloxavir targets, binds to and inhibits the CEN activity of the influenza polymerase acidic (PA) protein, an influenza virus-specific enzyme in the viral RNA polymerase complex required for the initiation of influenza gene transcription. By inhibiting PA endonuclease, influenza virus mRNA replication is halted. This reduces viral load and prevents further influenza infection.

Baloxavir Marboxil Manufacturers

A Baloxavir Marboxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baloxavir Marboxil, including repackagers and relabelers. The FDA regulates Baloxavir Marboxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baloxavir Marboxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Baloxavir Marboxil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Baloxavir Marboxil Suppliers

A Baloxavir Marboxil supplier is an individual or a company that provides Baloxavir Marboxil active pharmaceutical ingredient (API) or Baloxavir Marboxil finished formulations upon request. The Baloxavir Marboxil suppliers may include Baloxavir Marboxil API manufacturers, exporters, distributors and traders.

click here to find a list of Baloxavir Marboxil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Baloxavir Marboxil KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Baloxavir Marboxil Drug Master File in Korea (Baloxavir Marboxil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Baloxavir Marboxil. The MFDS reviews the Baloxavir Marboxil KDMF as part of the drug registration process and uses the information provided in the Baloxavir Marboxil KDMF to evaluate the safety and efficacy of the drug.

After submitting a Baloxavir Marboxil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Baloxavir Marboxil API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Baloxavir Marboxil suppliers with KDMF on PharmaCompass.

Baloxavir Marboxil Manufacturers | Traders | Suppliers

Baloxavir Marboxil Manufacturers, Traders, Suppliers 1
37

We have 1 companies offering Baloxavir Marboxil

Get in contact with the supplier of your choice:

  1. Shiono Finesse
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY